REGENXBIO2020-02-15T23:16:23-08:00
REGENXBIO

REGENXBIO

REGENXBIO (NASDAQ: RGNX) is a gene therapy platform company that is leveraging its proprietary NAV® Technology to advance the development of life-changing adeno-associated viral (AAV) treatments for lysosomal storage disorders, ocular diseases, and other unmet clinical needs.

Zai Lab2020-02-15T23:14:06-08:00
Zai Lab

Zai Lab

Zai Lab is a Shanghai-based biopharmaceutical company. Our globally-experienced drug development team is passionate about bringing transformative medicines to China and discovering and developing our own therapeutics for patients worldwide.